Literature DB >> 3484709

Effect of simulated systemic administration of aspirin, salicylate, and indomethacin on amphibian gastric mucosa.

P H Rowe, M J Starlinger, E Kasdon, G Marrone, W Silen.   

Abstract

The effects of 20 mM aspirin (ASA), 20 mM sodium salicylate (SA), or 10(-4) M indomethacin placed in the nutrient solution (N) to stimulate systemic administration were investigated at pHN 7.3 in Ussing-chambered amphibian gastric mucosae. In histamine-stimulated tissues, the initial rise and subsequent rapid fall in potential difference, rise in resistance, and inhibition of hydrogen ion (H+) secretion induced by SAN did not occur with ASAN unless hydrolysis of ASAN produced a SAN of greater than 3 mM. In metiamide-treated tissues, 20 mM SAN caused an immediate fall in potential difference and an increase in resistance; 2 mM SAN and 20 mM ASA produced similar qualitative electrical changes, but only those induced by ASA were reversible. IndomethacinN caused no significant changes in potential difference, resistance, or H+ secretion in histamine- or metiamide-treated tissues. Despite producing highly significant reductions in generation of prostaglandin E2, and prostaglanndin F2 alpha and 6-keto prostaglandin F1 alpha, ASAN and indomethacin caused no surface ulceration. Sodium salicylate placed in the nutrient solution caused only a small reduction in prostaglandin F2 alpha, without change in the other prostaglandins, and produced extensive edema in the lamina propria, histologically. We conclude the following: (a) The inhibition of H+ secretion and electrical changes caused by SAN in histamine-treated gastric fundus are not observed with ASAN unless there is hydrolysis to [SAN] greater than 3 mM. (b) Our data strongly implicate the SAN in ASAN-containing solutions as being responsible for the electrical effects and inhibition of H+ secretion. (c) There is no correlation in vitro between inhibition of prostaglandin synthesis and the electrical or morphologic changes produced by nutrient exposure to ASA, SA, or indomethacin.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3484709     DOI: 10.1016/0016-5085(86)91109-1

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  7 in total

1.  Non-steroidal anti-inflammatory drugs and prostaglandin effects on pepsinogen secretion by dispersed human peptic cells.

Authors:  A I Lanas; J Nerín; F Esteva; R Sáinz
Journal:  Gut       Date:  1995-05       Impact factor: 23.059

2.  Gastric cytoprotection by colloidal bismuth subcitrate (De-Nol) and sucralfate. Role of endogenous prostaglandins.

Authors:  P H Rowe; P R Taylor; R C Mason
Journal:  Gut       Date:  1987-10       Impact factor: 23.059

3.  Effects of misoprostol on delayed ulcer healing induced by aspirin.

Authors:  A G Penney; F J Andrews; P E O'Brien
Journal:  Dig Dis Sci       Date:  1994-05       Impact factor: 3.199

4.  Elemental diet and IV-TPN-induced bacterial translocation is associated with loss of intestinal mucosal barrier function against bacteria.

Authors:  E A Deitch; D Xu; M B Naruhn; D C Deitch; Q Lu; A A Marino
Journal:  Ann Surg       Date:  1995-03       Impact factor: 12.969

5.  Inability of cytoprotection to occur during a period of gastric ischemia.

Authors:  G M Frydman; A G Penney; C Malcontenti; P E O'Brien
Journal:  Dig Dis Sci       Date:  1991-10       Impact factor: 3.199

6.  Adenosine protects against indomethacin-induced gastric damage in rats.

Authors:  A Bozkurt; M Yüksel; G Haklar; H Kurtel; B C Yeğen; I Alican
Journal:  Dig Dis Sci       Date:  1998-06       Impact factor: 3.199

7.  Reye's syndrome and aspirin.

Authors:  P H Rowe
Journal:  J R Soc Med       Date:  1987-05       Impact factor: 18.000

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.